Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ventyx Biosciences, Inc. (VTYX)  
$4.09 0.39 (8.71%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 50,296,000
Market Cap: 205.71(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.9 - $40.3
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Ventyx Biosciences is a clinical-stage biopharmaceutical company engaged in the development of therapies for patients living with inflammatory diseases and autoimmune disorders. Co.'s product candidate is VTX958, an oral, selective clinical-stage tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis and Crohn's disease, among other potential indications. In addition, Co. is developing VTX002, an oral, selective sphingosine 1 phosphate receptor 1 modulator for ulcerative colitis. Co.'s oral, selective and peripherally restricted NLRP3 inhibitor, VTX2735, has been designed to treat systemic inflammatory diseases, such as cardiovascular, hepatic, renal and rheumatologic diseases.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 9,019 90,800 3,592,266 6,036,052
Total Sell Value $48,733 $221,937 $56,317,001 $133,915,096
Total People Sold 4 4 7 8
Total Sell Transactions 4 7 60 103
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 178
  Page 7 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Auster Martin Chief Financial Officer   •       –      –    2022-12-02 4 S $29.01 $2,832,603 D/D (97,647) 47,649 -3%     
   Auster Martin Chief Financial Officer   •       –      –    2022-12-02 4 OE $3.45 $172,500 D/D 50,000 145,296     -
   Nsv Partners Iii Gp Llc 10% Owner   –       –       •   2022-12-01 4 S $29.01 $3,751,150 I/I (129,317) 16,616,048 -4%     
   Subramaniam Somu Director   –       •       •   2022-12-01 4 S $29.01 $3,751,150 I/I (129,317) 16,616,048 -4%     
   Nsv Partners Iii Gp Llc 10% Owner   –       –       •   2022-11-30 4 S $29.01 $4,155,732 I/I (143,228) 16,745,365 -3%     
   Subramaniam Somu Director   –       •       •   2022-11-30 4 S $29.01 $4,155,732 I/I (143,228) 16,745,365 -3%     
   Subramaniam Somu Director   –       •       •   2022-11-07 4 S $29.08 $114,427 I/I (3,935) 16,888,593 -52%     
   Nsv Partners Iii Gp Llc 10% Owner   –       –       •   2022-11-07 4 S $29.08 $114,427 I/I (3,935) 16,888,593 -52%     
   Krueger Christopher W Chief Business Officer   •       –      –    2022-08-23 4 OE $0.20 $33,872 D/D 169,361 352,692     -
   Sandborn William J. See RemarksOfficer   •       –      –    2022-05-09 3 IO $0.00 $0 I/I 0 34,877 147%     
   Sandborn William J. See RemarksOfficer   •       –      –    2022-05-09 3 IO $0.00 $0 D/D 0 48,389 147%     
   Krueger Christopher W Chief Business Officer   •       –      –    2022-04-03 4 AS $32.88 $493,166 D/D (15,000) 276,117 39%     
   Krueger Christopher W Chief Business Officer   •       –      –    2022-04-03 4 OE $3.54 $32,040 D/D 8,447 291,117     -
   Cormorant Private Healthcare Fund Iii Lp 10% Owner   –       –       •   2021-10-25 4 B $16.00 $10,000,000 I/I 625,000 1,410,303 1.5 -33%     
   Cormorant Private Healthcare Fund Iii Lp 10% Owner   –       –       •   2021-10-25 4 A $0.00 $0 I/I 785,303 785,303     -
   Royston Aaron Director   –       •       •   2021-10-25 4 B $16.00 $5,000,000 I/I 312,500 3,997,269 2.25 -33%     
   Royston Aaron Director   –       •       •   2021-10-25 4 A $0.00 $0 I/I 3,684,769 3,684,769     -
   Goodman Corey S See Remarks   –       –       •   2021-10-25 4 B $16.00 $5,000,000 D/D 312,500 3,997,269 2.45 -33%     
   Goodman Corey S See Remarks   –       –       •   2021-10-25 4 A $0.00 $0 D/D 3,684,769 3,684,769     -
   Subramaniam Somu Director   –       •       •   2021-10-25 4 A $0.00 $0 I/I 16,892,528 16,892,528     -
   Gujrathi Sheila Director   –       •      –    2021-10-25 4 A $0.00 $0 D/D 32,897 32,897     -
   Nsv Partners Iii Gp Llc 10% Owner   –       –       •   2021-10-25 4 A $0.00 $0 I/I 16,892,528 16,892,528     -
   Nuss John Chief Scientific OfficerOffice   •       –      –    2021-10-20 3 IO $0.00 $0 D/D 0 308,696     -
   Mohan Raju Chief Executive OfficerOfficer   •       •      –    2021-10-20 3 IO $0.00 $0 D/D 0 1,841,811     -
   Krueger Christopher W Chief Business OfficerOfficer   •       –      –    2021-10-20 3 IO $0.00 $0 D/D 0 183,331     -
  178 Records found
  1  2  3  4  5  6  7  8   
  Page 7 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us